| Obinutuzumab investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 68show all (up to 200) |
|---|
| → investigated in trials for | Chronic Lymphocytic Leukemiahematologic_malignancy 85 trials (46 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Chronic Lymphocytic Leukemia | 85 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Small Lymphocytic Lymphoma 34 trials (25 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Small Lymphocytic Lymphoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Follicular Lymphomahematologic_malignancy 32 trials (12 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Follicular Lymphoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Non-Hodgkin Lymphomahematologic_malignancy 28 trials (9 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Non-Hodgkin Lymphoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mantle Cell Lymphomahematologic_malignancy 25 trials (16 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Mantle Cell Lymphoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Diffuse Large B-Cell Lymphoma 21 trials (11 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Diffuse Large B-Cell Lymphoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lymphomacancer_family 21 trials (9 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lymphoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | B-Cell Malignant Neoplasm 16 trials (7 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | B-Cell Malignant Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Marginal Zone Lymphoma 15 trials (7 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Marginal Zone Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Grade 3a Follicular Lymphoma 10 trials (6 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Grade 3a Follicular Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Grade 1 Follicular Lymphoma 9 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Grade 1 Follicular Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Grade 2 Follicular Lymphoma 9 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Grade 2 Follicular Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leukemiacancer_family 7 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Leukemia | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Burkitt Lymphomahematologic_malignancy 6 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Burkitt Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Indolent Non-Hodgkin Lymphoma 6 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Indolent Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |